Staff
-
ProfessorTomio UenoTomio Ueno
-
Professor with Special AssignmentYoshinori FujiwaraYoshinori Fujiwara
-
Professor with Special AssignmentKazuhiko YoshimatsuKazuhiko Yoshimatsu
-
Associate ProfessorShunji EndoShunji Endo
-
Associate ProfessorToshimasa OkadaToshimasa Okada
-
Assistant ProfessorMasaharu HigashidaMasaharu Higashida
-
Assistant ProfessorSyuuya YanoSyuuya Yano
-
Assistant ProfessorKei FuruyaKei Furuya
-
InstructorSyumei MinetaSyumei Mineta
-
InstructorMichi UenoMichi Ueno
-
InstructorShingo SaekiShingo Saeki
-
InstructorHironobu KanbaraHironobu Kanbara
-
InstructorMasaaki HoriMasaaki Hori
-
InstructorTakahiro InoueTakahiro Inoue
This department consists of 3 sections: upper gastrointestinal section, lower gastrointestinal section, and hepatobiliary and pancreatic surgery section
Research projects
- Analysis of human small intestinal submucosa and preparation of grafts by decellularization
We analysis human small intestinal submucosa (SIS) removed during surgery and decellularize them on a petri dish. We test various decellularization processes for human SIS graft in which we keep the native structure of the extracellular matrix and optimal conditions of growth/proliferation factors.
- Development of a new therapeutic strategy for unresectable poorly differentiated gastric cancer with the aim of suppressing c-MET signaling pathway
We are focusing on c-MET inhibitors in order to develop a pharmacotherapy regimen aimed at conversion therapy with excellent tumor-reducing effect that leads to R0 resection in patients with poorly differentiated adenocarcinoma of the stomach. This study is carried out to evaluate the combined effects of c-MET inhibitor and anticancer agents in vitro and in vivo using poorly differentiated gastric adenocarcinoma cell lines. Furthermore, we are also studying the combined effect (synergistic effect) with STAT3 and c-MET inhibitors under the same conditions.
We expect to develop a new therapeutic strategy for unresectable gastric cancer patients with poorly differentiated adenocarcinoma.
- Research on relationship between Brachyury expression and prognosis in gastrointestinal stromal tumor (GIST)
We are analyzing Brachyury expression by immunohistochemistry in a cohort of GIST patients with a confirmed diagnosis, and are examining its relationship with prognosis. If the Branchyury immunostaining score can be a predictor of prognosis, GIST patients will be able to have a new treatment option.